Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Invested Capital (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Invested Capital data on record, last reported at $24.7 million in Q4 2025.

  • For Q4 2025, Invested Capital rose 17.14% year-over-year to $24.7 million; the TTM value through Dec 2025 reached $24.7 million, up 17.14%, while the annual FY2025 figure was $24.7 million, 17.14% up from the prior year.
  • Invested Capital reached $24.7 million in Q4 2025 per VRCA's latest filing, up from $4.6 million in the prior quarter.
  • Across five years, Invested Capital topped out at $102.5 million in Q1 2021 and bottomed at $4.6 million in Q3 2025.
  • Average Invested Capital over 5 years is $49.0 million, with a median of $50.1 million recorded in 2022.
  • Peak YoY movement for Invested Capital: soared 89.22% in 2023, then plummeted 89.07% in 2024.
  • A 5-year view of Invested Capital shows it stood at $74.3 million in 2021, then tumbled by 46.12% to $40.0 million in 2022, then surged by 56.46% to $62.6 million in 2023, then tumbled by 66.28% to $21.1 million in 2024, then grew by 17.14% to $24.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $24.7 million in Q4 2025, $4.6 million in Q3 2025, and $7.1 million in Q2 2025.